Skip to main content
. 2022 Mar 14;45(2):e275–e284. doi: 10.1093/pubmed/fdac032

Table 3.

Psychological outcomes in the positive test (+ve) and CGs (no test) from 1 to 12 months

1m 3m 6m 12m
+ve test, M (SD) No test, M (SD) Adj. diff. in means [95% CI] +ve test, M (SD) No test, M (SD) Adj. diff. in means [95% CI] +ve test, M (SD) No test, M (SD) Adj. diff. in means [95% CI] +ve test, M (SD) No test, M (SD) Adj. diff. in means [95% CI] P-value diff. between groups over time
PANAS positive 31.87 (8.62) 30.61 (8.50) 0.54 [−0.60, 1.57] 30.29 (9.14) 30.00 (8.39) −0.20 [−1.34, 0.94] 30.90 (9.68) 30.15 (9.25) 0.28 [−0.85, 1.43] 31.11 (9.92) 30.43 (9.49) 0.45 [−0.71, 1.60] 0.56
PANAS negative 16.47 (7.15) 16.94 (7.53) 16.17 (7.25) 17.29 (7.83) 16.02 (6.97) 17.03 (8.00) 16.23 (7.61) 16.97 (8.10)
PANAS negative (log) 2.72 (0.38) 2.75 (0.39) −0.01 [−0.07, 0.04] 2.70 (0.39) 2.76 (0.40) −0.06 [−0.12, 0.00] 2.70 (0.37) 2.75 (0.40) −0.03 [−0.09, 0.03] 2.70 (0.39) 2.74 (0.41) −0.03 [−0.09, 0.03] 0.29
LCWS—impact 3.39 (1.62) 3.28 (1.63) 0.13 [−0.08, 0.34] 3.34 (1.60) 3.31 (1.60) 0.01 [−0.20, 0.22] 3.29 (1.60) 3.30 (1.64) 0.01 [−0.22, 0.21] 3.22 (1.66) 3.35 (1.60) −0.12 [−0.33, 0.09] 0.09
+ve test, N (%) No test, N (%) OR [95% CI] +ve test, N (%) No test, N (%) OR [95% CI] +ve test, N (%) No test, N (%) OR [95% CI] +ve test, N (%) No test, N (%) OR [95% CI]
LCWS—frequency 200 (64.52) 214 (62.76) 1.65 [0.84, 3.21] 186 (61.59) 207 (62.35) 1.17 [0.60, 2.29] 191 (64.09) 204 (62.01) 1.61 [0.82, 3.16] 168 (58.74) 196 (61.64) 0.99 [0.50, 1.95] 0.45
LCWS—worry 73 (23.55) 52 (15.25) 3.40 [1.69, 6.84] 55 (18.27) 56 (16.92) 1.43 [0.70, 2.91] 54 (18.24) 57 (17.48) 1.30 [0.64, 2.65] 50 (17.48) 68 (21.52) 0.71 [0.35, 1.44] 0.002

Adjusted for study site (Greater Glasgow and Clyde, Tayside), minimization variables (age group, gender and smoking history) and baseline values where measured. M = mean. 1m = 1 month, 3m = 3 months, 6m = 6 months, 12m = 12 months.